Day 3 - Wednesday, May 20 2026Wednesday, 20 May 2026 - ET (Eastern Time, GMT-05:00)

Showing 1 of 1 Streams

Networking Break

7:30am - 8:00am

Breakfast, Coffee and Registration

Showing 1 of 1 Streams

General Session

8:00am - 8:15am

Co-Chair's Opening Remarks

8:15am - 8:55amLive Stream

Government Keynote on Policy Updates TBA

8:55am - 9:35amLive Stream

MFN Agreements: Unraveling the Complexities of HHS-Manufacturer Negotiations

This session delves into the intricacies of Most Favored Nation (MFN) agreements and the unconventional dynamics shaping negotiations between the U.S. Department of Health and Human Services (HHS) and manufacturers.

John Shakow - Partner, King & Spalding LLP

9:35am - 10:30amLive Stream

Fireside Chat: External Counsel Roundtable

Hear from an expert panel of attorneys as they each moderate a topic and interactive discussion among attendees, and themselves, on the most pressing issues facing government and commercial contracting, pricing and reporting.

Tom Evegan - Principal, National Consulting Leader, Life Sciences, RSM US LLP
Margaux Hall - Partner, Ropes & Gray LLP
Stephanie Trunk - Partner, ArentFox Schiff LLP

Showing 1 of 1 Streams

Networking Break

10:30am - 11:00am

Morning Networking Break

Showing 2 of 2 Streams

Track C: Intentional Commercial Contracting, Chargebacks & Rebate Operations

Track D: Pricing and Contracting Cell & Gene Therapy

11:00am - 11:40am

Federal Contracting Excellence: Mastering VA, DOD, and FSS Strategies

Develop integrated approaches for managing VA, DOD, FSS, and NFAMP contracts while ensuring proper government pricing calculations and avoiding compliance conflicts
Optimize SAM.gov processes and federal solicitation response strategies
Implement best practices for registration maintenance, solicitation monitoring, and proposal development that maximize contract award opportunities while minimizing administrative burden
Create cross-functional processes that prevent government pricing violations while enabling strategic commercial contracting decisions and maintaining competitive market positions

11:40am - 12:20pm

Advanced Chargeback Operations: Next-Gen WAC Management and System Integration

Establish comprehensive dispute resolution processes that balance efficiency with accuracy
Optimize data exchange and communication protocols with major wholesaler partners
System integration challenges across multiple platforms
Advanced validation rules and exception handling
Crisis management and system redundancy planning

11:00am - 11:05amLive Stream

Cell and Gene Therapies Market Access State of Affairs

Explore market access strategies as CAR-T therapies expand into autoimmune conditions like lupus, addressing the unique challenges of transitioning from academic centers to rheumatology practices and community settings
Build compelling value propositions using long-term outcome data, hospitalization avoidance metrics, and lifetime treatment cost comparisons that demonstrate CGT's curative potential versus chronic disease management
Tackle the margin pressures hospitals face with CGT administration, including multi-dose reimbursement complexities, 340B pricing disputes, and the administrative burden of center certification and authorization processes
Explore innovative contracting models beyond traditional outcomes-based agreements
Create collaborative frameworks that address price protection requests, streamline prior authorization processes, and support centers in navigating the complex reimbursement landscape while maintaining sustainable business models

11:05am - 11:45amLive Stream

From Lab to Patient: Optimizing CGT Manufacturing Costs and Supply Chain Resilience

Address the manufacturing challenges that impact CGT pricing sustainability, exploring automation, process optimization, and scale economies that can support more competitive pricing models
Navigate international manufacturing and tariff implications
Build manufacturing and distribution systems that accommodate the unique logistics requirements of patient-specific CGT products while maintaining quality and reducing waste
Optimize inventory management for limited-shelf-life products -
Establish quality assurance frameworks across manufacturing partners

Showing 2 of 2 Streams

Networking Break

Closed Door Executive Strategy Summit and Luncheon

12:20pm - 1:20pm

Networking Luncheon

12:20pm - 1:20pm

Closed Door Executive Strategy Summit and Luncheon

Join fellow senior leaders for an elevated lunch experience where you'll engage in facilitator-guided conversations on mission-critical topics impacting pharmaceutical manufacturers in 2026, including Medicare Part B negotiations, MFN, 340B rebate model, CMS final rule, evolving PBM dynamics, state-level policy shifts, and strategic GTN management. This closed-door session provides a confidential environment for authentic dialogue and solution sharing.

Invitation-only gathering limited to 35 participants

Barrett Land - Vice President - Pricing & Contracting & Reimbursement, Jazz Pharmaceutical
Suzie Tam-Porter - VP, Channel & Contract Management, Genentech

Showing 1 of 1 Streams

General Session

1:30pm - 2:10pm

Site of Care Mastery: From Strategy to Execution

Rich Toner - Division Chair, Reimbursement & Pricing, Mayo Clinic

2:10pm - 2:50pm

Direct-to-Consumer Pharma Initiatives: Implementation Strategy and Market Reality Check

Sharon Small - Director, Counsel Market Access, Government Pricing & Policy, Novartis Pharmaceuticals Corporation

2:50pm - 3:30pm

OIG Update on Compliance and Oversight Activities

Perspective on the OIG's oversight role amidst evolving drug pricing and contracting practices

Tanaz Dutia - Team Leader and Rapid Response Technical Expert, Office of Inspector General
Edward Burley - Deputy Regional Inspector General, Office of Inspector General, U.S. Department of Health and Human Services

3:30pm - 3:50pm

Close of Conference – See you in 2027!